ReviewMedicine2025
Pediatric thrombosis: Risk factors, diagnosis, and prevention strategies.
Review in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Pediatric venous thromboembolism: an illustrated review.Research and practice in thrombosis and haemostasis · 2026Review
- Pediatric Stroke in Asia and Africa: Epidemiology, Etiology, and Resource-Stratified Care Across Geographic and System-Level Disparities.Journal of central nervous system disease · 2026Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pediatric thrombosis is an underdiagnosed condition with potentially life-threatening consequences. Unlike adult thrombosis, the pediatric variant is characterized by age-specific risk factors, such as central venous catheters, infections, and genetic predispositions, which demand a tailored approach to diagnosis and management. Neonates and adolescents are particularly vulnerable due to physiological and hormonal changes, respectively, that amplify their susceptibility to thrombotic events. A deeper understanding of these factors is crucial for early detection and effective prevention strategies. The diagnostic process for pediatric thrombosis is fraught with challenges owing to the nonspecific nature of symptoms and variability in presentation across age groups. Imaging modalities, such as Doppler ultrasound and computed tomography pulmonary angiography, remain the cornerstone for identifying thrombotic events. However, laboratory investigations, including thrombophilia testing and d-dimer assays, are essential adjuncts, particularly in cases of idiopathic or recurrent thrombosis. Timely and accurate diagnosis is pivotal for reducing morbidity and mortality associated with this condition.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.